Resona Asset Management Co.,Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1944142 KOTO-KU,TOKYO, M0

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$6,568,677

+$835,089 QoQ

Shares Held

38,974

-10.4% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#185

of 768 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Resona Asset Management Co.,Ltd. holds $35,396,772 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (18.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	316,361	$10,718,310
2	ZTS	Zoetis Inc.	124,635	$8,956,271
3	UTHR	UNITED THERAPEUTICS Corp	15,391	$8,339,305
4	NBIX	Neurocrine Biosciences Inc This page	38,974	$6,568,677
5	SUPN	Supernus Pharmaceuticals, Inc.	9,035	$420,217
6	VTRS	Viatris Inc	17,063	$270,960
7	LNTH	Lantheus Holdings, Inc.	1,109	$123,032

All Filings in NBIX

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,568,677	38,974	-10.4%	Shares	Other	2026-07-29
2026-03-31	$5,733,588	43,522	-10.1%	Shares	Other	2026-04-30
2025-12-31	$6,865,422	48,406	-1.8%	Shares	Other	2026-02-06
2025-09-30	$6,923,260	49,318	-6.1%	Shares	Other	2025-10-31
2025-06-30	$6,604,758	52,548	+3.1%	Shares	Other	2025-08-06
2025-03-31	$5,636,950	50,967	+2.3%	Shares	Other	2025-05-13
2024-12-31	$6,802,887	49,838	-2.1%	Shares	Other	2025-02-13
2024-09-30	$5,863,661	50,891	-0.4%	Shares	Other	2025-02-20
2024-06-30	$7,036,589	51,112	+1.7%	Shares	Other	2025-02-20
2024-03-31	$6,932,135	50,262	—	Shares	Other	2025-02-20
No filing history on record for this holder in this stock.